India’s biotech sector is expected to grow at a robust 20 per cent per annum in the near future, given the growing demand for biopharmaceuticals, biosimilars and vaccines, says a veteran in the field. Biofuels would also offer a huge growth opportunity in biotech, the Chairman and Managing Director of Biocon, the country’s largest biotech company by revenue, Kiran Mazumdar-Shaw said.